Cantor Fitzgerald restated their overweight rating on shares of EVE (NYSE:EVEX – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. The firm currently has a $5.00 price objective on the stock.
EVEX has been the topic of a number of other reports. HC Wainwright initiated coverage on shares of EVE in a research note on Tuesday, September 3rd. They issued a buy rating and a $6.00 target price on the stock. Canaccord Genuity Group lowered their price objective on shares of EVE from $9.00 to $8.50 and set a buy rating on the stock in a research report on Tuesday, July 2nd.
Check Out Our Latest Analysis on EVEX
EVE Stock Up 2.2 %
EVE (NYSE:EVEX – Get Free Report) last posted its earnings results on Tuesday, August 6th. The company reported ($0.13) EPS for the quarter, hitting the consensus estimate of ($0.13). Equities research analysts expect that EVE will post -0.49 earnings per share for the current fiscal year.
Institutional Trading of EVE
An institutional investor recently raised its position in EVE stock. Vanguard Group Inc. increased its holdings in Eve Holding, Inc. (NYSE:EVEX – Free Report) by 7.1% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 517,707 shares of the company’s stock after purchasing an additional 34,484 shares during the period. Vanguard Group Inc. owned approximately 0.19% of EVE worth $2,796,000 as of its most recent SEC filing. Institutional investors own 1.27% of the company’s stock.
EVE Company Profile
Eve Holding, Inc, together with its subsidiaries, develops urban air mobility solutions. It is involved in the design and production of electrical vertical take-off and landing vehicles (eVTOLs); provision of eVTOL service and support capabilities, including material services, maintenance, technical support, training, ground handling, and data services; and development of urban air traffic management systems.
Further Reading
- Five stocks we like better than EVE
- What is Forex and How Does it Work?
- Goldilocks CPI Report Leads Market to Sell Off, Lower Lows Ahead
- Top Biotech Stocks: Exploring Innovation Opportunities
- GameStop: Earnings Won’t Save It, Dilution Points to Trouble
- Transportation Stocks Investing
- Dividend Aristocrats or Dividend Kings: Which Is Best for You?
Receive News & Ratings for EVE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EVE and related companies with MarketBeat.com's FREE daily email newsletter.